Clinical trial
Amaranth Endovascular Study of a Drug-Eluting Bioresorbable Coronary Scaffold
NCT02189499 is registered in ClinicalTrials.gov with Amaranth Medical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amaranth Endovascular Study of a Drug-Eluting Bioresorbable Coronary Scaffold
- Lead sponsor
- Amaranth Medical Inc.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- November 30, 2020
- Enrollment
- 42 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.